Surgical Pathology Clinics

Testicular Cancer

Contemporary Updates in Staging


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgical Pathology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Magers M.J.
        • Idrees M.T.
        Updates in staging and reporting of testicular cancer.
        Surg Pathol Clin. 2018; 11: 813-824
        • Carr D.T.
        The manual for the staging of cancer.
        Ann Intern Med. 1977; 87: 491-492
        • Al-Obaidy K.I.
        • Chovanec M.
        • Cheng L.
        Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance.
        Expert Rev Anticancer Ther. 2020; 20: 75-79
        • Delahunt B.
        • Egevad L.
        • Samaratunga H.
        • et al.
        UICC drops the ball in the 8th edition TNM staging of urological cancers.
        Histopathology. 2017; 71: 5-11
        • Amin M.B.
        • Greene F.L.
        • Edge S.B.
        • et al.
        The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
        CA Cancer J Clin. 2017; 67: 93-99
        • Balzer B.L.
        • Ulbright T.M.
        Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
        Am J Surg Pathol. 2006; 30: 858-865
        • Emerson R.E.
        • Ulbright T.M.
        Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.
        Pathology. 2010; 42: 344-355
        • Chung P.
        • Daugaard G.
        • Tyldesley S.
        • et al.
        Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.
        Cancer Med. 2015; 4: 155-160
        • Mortensen M.S.
        • Lauritsen J.
        • Gundgaard M.G.
        • et al.
        A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
        Eur Urol. 2014; 66: 1172-1178
        • Aparicio J.
        • Maroto P.
        • Garcia Del Muro X.
        • et al.
        Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).
        Ann Oncol. 2014; 25: 2173-2178
        • Warde P.
        • Specht L.
        • Horwich A.
        • et al.
        Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
        J Clin Oncol. 2002; 20: 4448-4452
        • Kamba T.
        • Kamoto T.
        • Okubo K.
        • et al.
        Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients.
        Int J Urol. 2010; 17: 980-987
        • Yilmaz A.
        • Cheng T.
        • Zhang J.
        • et al.
        Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors.
        Mod Pathol. 2013; 26: 579-586
        • Vogt A.P.
        • Chen Z.
        • Osunkoya A.O.
        Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding?.
        Hum Pathol. 2010; 41: 1339-1344
        • Berney D.M.
        • Algaba F.
        • Amin M.
        • et al.
        Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists.
        Histopathology. 2015; 67: 313-324
        • Alexandre J.
        • Fizazi K.
        • Mahé C.
        • et al.
        Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse.
        Eur J Cancer. 2001; 37: 576-582
        • Daugaard G.
        • Gundgaard M.G.
        • Mortensen M.S.
        • et al.
        Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
        J Clin Oncol. 2014; 32: 3817-3823
        • Lu K.
        Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
        J Clin Oncol. 2015; 33: 2322
        • Verrill C.
        • Yilmaz A.
        • Srigley J.R.
        • et al.
        Reporting and staging of testicular germ cell tumors: the international society of urological pathology (ISUP) testicular cancer consultation conference recommendations.
        Am J Surg Pathol. 2017; 41: e22-e32
        • Nazeer T.
        • Ro J.Y.
        • Kee K.H.
        • et al.
        Spermatic cord contamination in testicular cancer.
        Mod Pathol. 1996; 9: 762-766
        • McCleskey B.C.
        • Epstein J.I.
        • Albany C.
        • et al.
        the significance of lymphovascular invasion of the spermatic cord in the absence of cord soft tissue invasion.
        Arch Pathol Lab Med. 2017; 141: 824-829
        • Sanfrancesco J.M.
        • Trevino K.E.
        • Xu H.
        • et al.
        The significance of spermatic cord involvement by testicular germ cell tumors: should we be staging discontinuous invasion from involved lymphovascular spaces differently from direct extension?.
        Am J Surg Pathol. 2018; 42: 306-311
        • Coursey Moreno C.
        • Small W.C.
        • Camacho J.C.
        • et al.
        Testicular tumors: what radiologists need to know--differential diagnosis, staging, and management.
        Radiographics. 2015; 35: 400-415
        • Hedgire S.S.
        • Pargaonkar V.K.
        • Elmi A.
        • et al.
        Pelvic nodal imaging.
        Radiol Clin North Am. 2012; 50: 1111-1125
        • Ehrlich Y.
        • Beck S.D.
        • Foster R.S.
        • et al.
        Serum tumor markers in testicular cancer.
        Urol Oncol. 2013; 31: 17-23
        • Masterson T.A.
        • Rice K.R.
        • Beck S.D.
        Current and future biologic markers for disease progression and relapse in testicular germ cell tumors: a review.
        Urol Oncol. 2014; 32: 261-271
        • Chakiryan N.H.
        • Dahmen A.
        • Cucchiara V.
        • et al.
        Reliability of serum tumor marker measurement to diagnose recurrence in patients with clinical stage I nonseminomatous germ cell tumors undergoing active surveillance: a systematic review.
        J Urol. 2021; 205: 1569-1576
        • Bosl G.J.
        • Motzer R.J.
        Testicular germ-cell cancer.
        N Engl J Med. 1997; 337: 242-253
        • Alvarado-Cabrero I.
        • Hernandez-Toriz N.
        • Paner G.P.
        Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis.
        Am J Surg Pathol. 2014; 38: 111-118
        • Hassan O.
        • Epstein J.I.
        The clinical significance of a small component of choriocarcinoma in testicular mixed germ cell tumor (MGCT).
        Am J Surg Pathol. 2018; 42: 1113-1120
        • Gilbert S.M.
        • Daignault S.
        • Weizer A.Z.
        • et al.
        The use of tumor markers in testis cancer in the United States: a potential quality issue.
        Urol Oncol. 2008; 26: 153-157
        • Gilligan T.D.
        • Seidenfeld J.
        • Basch E.M.
        • et al.
        American society of clinical oncology clinical practice guideline on uses of serum tumor markers in adult males with germ cell tumors.
        J Clin Oncol. 2010; 28: 3388-3404
        • Skinner D.G.
        • Scardino P.T.
        Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
        J Urol. 1980; 123: 378-382
        • Albers P.
        • Albrecht W.
        • Algaba F.
        • et al.
        EAU guidelines on testicular cancer: 2011 update.
        Eur Urol. 2011; 60: 304-319
        • Albers P.
        • Albrecht W.
        • Algaba F.
        • et al.
        [EAU guidelines on testicular cancer: 2011 update. European Association of Urology].
        Actas Urol Esp. 2012; 36 (Guía clínica sobre el cáncer de testículo de la EAU: actualización de 2011): 127-145
        • IGCCC G.
        A prognostic factor based staging system for metastatic germ-cell cancers.
        J Clin Oncol. 1997; 15: 594-603
        • Kattan M.W.
        • Hess K.R.
        • Amin M.B.
        • et al.
        American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine.
        CA: A Cancer J Clinicians. 2016; 66: 370-374